1.
Bioorg Med Chem Lett
; 20(24): 7341-4, 2010 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21074426
RESUMO
The identification and subsequent optimisation of a selective non-peptidic NPY Y2 antagonist series is described. This led to the development of amine 2, a selective, soluble NPY Y2 receptor antagonist with enhanced CNS exposure.